{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T08:48:02Z","timestamp":1790326082294,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Bulletin du Cancer"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.bulcan.2025.06.008","type":"journal-article","created":{"date-parts":[[2025,9,4]],"date-time":"2025-09-04T11:10:17Z","timestamp":1756984217000},"page":"1376-1384","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Repr\u00e9sentation du risque infectieux chez les patients atteints de my\u00e9lome multiple\u00a0: une \u00e9tude prospective multicentrique visant \u00e0 adapter le r\u00f4le des infirmier(e)s en pratique avanc\u00e9e"],"prefix":"10.1016","volume":"112","author":[{"given":"Ludivine","family":"Besse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Moreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-8314-2980","authenticated-orcid":false,"given":"Michelle","family":"Delpy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.bulcan.2025.06.008_bib0150","first-page":"125","article-title":"My\u00e9lome multiple\u00a0: diagnostic clinique et perspective de traitement. Recommandations de l\u2019International Myeloma Working Group (IMWG)","volume":"26","author":"Manier","year":"2011","journal-title":"Immunol Biol Spec"},{"key":"10.1016\/j.bulcan.2025.06.008_bib0155","series-title":"Survie des personnes atteintes de cancer en France m\u00e9tropolitaine 1989-2018 \u2013 My\u00e9lome multiple et plasmocytome","author":"Monnereau","year":"2021"},{"issue":"9","key":"10.1016\/j.bulcan.2025.06.008_bib0160","doi-asserted-by":"crossref","first-page":"e1406","DOI":"10.1634\/theoncologist.2020-0141","article-title":"Multiple myeloma incidence and mortality around the globe; interrelations between health access and quality, economic resources, and patient empowerment","volume":"25","author":"Ludwig","year":"2020","journal-title":"Oncologist"},{"key":"10.1016\/j.bulcan.2025.06.008_bib0165","series-title":"Estimations nationales de l\u2019incidence et de la mortalit\u00e9 par cancer en France m\u00e9tropolitaine entre 1990\u00a0et 2018. Synth\u00e8se","first-page":"20","author":"Defossez","year":"2019"},{"issue":"2","key":"10.1016\/j.bulcan.2025.06.008_bib0170","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/S0889-8588(18)30341-1","article-title":"The epidemiology of multiple myeloma","volume":"6","author":"Riedel","year":"1992","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.bulcan.2025.06.008_bib0175","unstructured":"INSEE. \u00c9volution de la population\u00a0\u2013\u00a0tableaux de l\u2019\u00e9conomie fran\u00e7aise. \u00c9dition 2020. 27\/02\/2020 [cit\u00e9 le 10\u00a0octobre 2024]. Disponible sur\u00a0: https:\/\/www.insee.fr\/fr\/statistiques\/4277615?sommaire=4318291."},{"issue":"1","key":"10.1016\/j.bulcan.2025.06.008_bib0180","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3324\/haematol.2014.107714","article-title":"Multiple myeloma and infections: a population-based study on 9253\u00a0multiple myeloma patients","volume":"100","author":"Blimark","year":"2015","journal-title":"Haematologica"},{"issue":"2","key":"10.1016\/j.bulcan.2025.06.008_bib0185","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S2352-3026(21)00283-0","article-title":"Consensus guidelines and recommendations for infection prevention in multiple myeloma: a report from the International Myeloma Working Group","volume":"9","author":"Raje","year":"2022","journal-title":"Lancet Haematol"},{"issue":"1","key":"10.1016\/j.bulcan.2025.06.008_bib0190","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.medmal.2018.09.001","article-title":"Enqu\u00eate sur l\u2019\u00e9valuation des pratiques de pr\u00e9vention infectieuse dans le my\u00e9lome","volume":"49","author":"R\u00e9gny","year":"2019","journal-title":"Med Mal Infect"},{"issue":"3","key":"10.1016\/j.bulcan.2025.06.008_bib0195","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.annonc.2020.11.014","article-title":"Multiple myeloma: EHA-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"32","author":"Dimopoulos","year":"2021","journal-title":"Ann Oncol"},{"issue":"4","key":"10.1016\/j.bulcan.2025.06.008_bib0200","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.rhum.2016.02.017","article-title":"Zona: risques et pr\u00e9vention sous immuno-modulateurs","volume":"83","author":"Tran","year":"2016","journal-title":"Rev Rhum"},{"issue":"1","key":"10.1016\/j.bulcan.2025.06.008_bib0205","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/s41375-020-01016-0","article-title":"Recommendations for vaccination in multiple myeloma: a consensus of the European Myeloma Network","volume":"35","author":"Ludwig","year":"2021","journal-title":"Leukemia"},{"issue":"26","key":"10.1016\/j.bulcan.2025.06.008_bib0210","doi-asserted-by":"crossref","first-page":"3033","DOI":"10.1182\/blood.2020008150","article-title":"Clinical features associated with COVID-19\u00a0outcome in multiple myeloma: first results from the International Myeloma Society data set","volume":"136","author":"Chari","year":"2020","journal-title":"Blood"},{"key":"10.1016\/j.bulcan.2025.06.008_bib0215","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.medmal.2017.03.313","article-title":"HEXAVAC\u00a0\u2013\u00a0\u00e9valuation de la couverture vaccinale des patients en h\u00e9matologie sous chimioth\u00e9rapie","volume":"47","author":"Janssen","year":"2017","journal-title":"Med Mal Infect"},{"issue":"1","key":"10.1016\/j.bulcan.2025.06.008_bib0220","doi-asserted-by":"crossref","first-page":"10101","DOI":"10.1051\/tpe\/2017002","article-title":"\u00c9valuation des repr\u00e9sentations relatives aux m\u00e9dicaments chez les patients atteints de my\u00e9lome multiple","volume":"9","author":"Huon","year":"2017","journal-title":"Educ Ther Patient"},{"issue":"4","key":"10.1016\/j.bulcan.2025.06.008_bib0225","doi-asserted-by":"crossref","first-page":"396","DOI":"10.9734\/BJAST\/2015\/14975","article-title":"Likert scale: explored and explained","volume":"7","author":"Joshi","year":"2015","journal-title":"BJAST"},{"key":"10.1016\/j.bulcan.2025.06.008_bib0230","series-title":"Chapitre 8. Analyser questions ouvertes et don\u00e9es textuelles. Big Quali La puissance des \u00e9tudes qualitatives \u00e0 l\u2019\u00e8re du Big Data","author":"B\u00f4","year":"2022"},{"issue":"1","key":"10.1016\/j.bulcan.2025.06.008_bib0235","doi-asserted-by":"crossref","first-page":"161","DOI":"10.4000\/questionsdecommunication.11097","article-title":"Contribution linguistique \u00e0 une classification automatique des communaut\u00e9s de sens et \u00e0 leur analyse. La controverse sur le statut des intermittents du spectacle","volume":"31","author":"Saigh","year":"2017","journal-title":"Questions Commun"},{"key":"10.1016\/j.bulcan.2025.06.008_bib0240","unstructured":"Commission nationale d\u2019informatique et des libert\u00e9s (CNIL) [Internet]. Disponible sur\u00a0: https:\/\/www.cnil.fr\/fr\/declaration\/mr-001-recherches-dans-le-domaine-de-la-sante-avec-recueil-du-consentement (Consult\u00e9 le 10\u00a0octobre 2024)."},{"key":"10.1016\/j.bulcan.2025.06.008_bib0245","unstructured":"Scherlinger M, Zein N, Kleinmann JF, Riviere M, Sibilia J, Arnaud L. Difficult\u00e9s et v\u00e9cu de la pand\u00e9mie Covid-19\u00a0des patients atteints de lupus syst\u00e9mique: r\u00e9sultats de l\u2019enqu\u00eate nationale EPICURE."},{"key":"10.1016\/j.bulcan.2025.06.008_bib0250","unstructured":"Larousse [en ligne]. Availalable from: https:\/\/www.larousse.fr\/encyclopedie\/medical\/infection\/13867 [cit\u00e9 le 3\u00a0janvier 2025]."},{"key":"10.1016\/j.bulcan.2025.06.008_bib0255","doi-asserted-by":"crossref","first-page":"811","DOI":"10.3917\/spub.176.0811","article-title":"Interventions en litt\u00e9ratie en sant\u00e9 et \u00e9ducation th\u00e9rapeutique\u00a0: une revue de la litt\u00e9rature","volume":"29","author":"Margat","year":"2017","journal-title":"Sante Publique"},{"key":"10.1016\/j.bulcan.2025.06.008_bib0260","series-title":"La diversit\u00e9 des trajectoires socio-spatiales de soin dans les parcours de soins coordonn\u00e9s","author":"Calvez","year":"2012"},{"key":"10.1016\/j.bulcan.2025.06.008_bib0265","first-page":"966","article-title":"My\u00e9lome multiple du sujet \u00e2g\u00e9\u00a0: entre \u00e9valuation de la fragilit\u00e9 des patients et progr\u00e8s de l\u2019immunoth\u00e9rapie","volume":"206","author":"Facon","year":"2022","journal-title":"Bull Acad Natl Med"},{"key":"10.1016\/j.bulcan.2025.06.008_bib0270","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.rhum.2021.10.264","article-title":"Infirmi\u00e8re en pratique avanc\u00e9e dans le my\u00e9lome multiple\u00a0: une prise en charge innovante pour les patients et les m\u00e9decins","volume":"88","author":"Sapet","year":"2021","journal-title":"Rev Rhum"},{"key":"10.1016\/j.bulcan.2025.06.008_bib0275","doi-asserted-by":"crossref","first-page":"e14268","DOI":"10.1111\/tid.14268","article-title":"Review of advanced practice nurse role in infection throughout the hematopoietic stem cell transplant journey","volume":"26","author":"Gilsenan","year":"2024","journal-title":"Transpl Infect Dis"},{"issue":"2","key":"10.1016\/j.bulcan.2025.06.008_bib0280","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ajic.2019.06.007","article-title":"Changements dans les politiques de contr\u00f4le des infections et promotion de la formation infirmi\u00e8re en pratique avanc\u00e9e de contr\u00f4le des infections en R\u00e9publique de Cor\u00e9e","volume":"48","author":"Choi","year":"2020","journal-title":"Am J Infect Control"},{"issue":"1","key":"10.1016\/j.bulcan.2025.06.008_bib0285","first-page":"21","article-title":"Apport d\u2019une IPA dans la prise en charge des patients en neuro-oncologie. Exp\u00e9rimentation \u00e0 l\u2019Institut de canc\u00e9rologie de l\u2019Ouest (ICO)","volume":"19","author":"Thomas","year":"2019","journal-title":"Bull Inf Cancer"},{"issue":"3","key":"10.1016\/j.bulcan.2025.06.008_bib0145","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.bulcan.2022.12.017","article-title":"Anticanc\u00e9reux oraux\u00a0: retour d\u2019exp\u00e9rience apr\u00e8s six ann\u00e9es de consultations tripartites dans un centre hospitalier","volume":"110","author":"Streicher","year":"2023","journal-title":"Bull Cancer"}],"container-title":["Bulletin du Cancer"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455125003431?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0007455125003431?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T20:31:30Z","timestamp":1763757090000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0007455125003431"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":29,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S0007455125003431"],"URL":"https:\/\/doi.org\/10.1016\/j.bulcan.2025.06.008","relation":{},"ISSN":["0007-4551"],"issn-type":[{"value":"0007-4551","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Repr\u00e9sentation du risque infectieux chez les patients atteints de my\u00e9lome multiple\u00a0: une \u00e9tude prospective multicentrique visant \u00e0 adapter le r\u00f4le des infirmier(e)s en pratique avanc\u00e9e","name":"articletitle","label":"Article Title"},{"value":"Bulletin du Cancer","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bulcan.2025.06.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Soci\u00e9t\u00e9 Fran\u00e7aise du Cancer. Published by Elsevier Masson SAS. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}